CorMedix (CRMD) Operating Leases (2019 - 2025)

CorMedix (CRMD) has 7 years of Operating Leases data on file, last reported at $2.3 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Leases rose 545.56% year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2025 stood at $2.3 million (up 545.56% YoY), and the FY2025 full-year result was $2.3 million, up 545.56% from the prior year.
• Operating Leases slipped to $2.3 million in Q4 2025, from $2.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $2.4 million in Q3 2025 to a low of $258000.0 in Q2 2025.
• A 5-year average of $803773.5 and a median of $685473.5 in 2022 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases surged 47205.04% in 2021 and slumped 56.57% in 2025, its largest moves.
• Tracing CRMD's Operating Leases over 5 years: stood at $802433.0 in 2021, then slipped by 16.75% to $668000.0 in 2022, then slipped by 22.6% to $517000.0 in 2023, then sank by 32.5% to $349000.0 in 2024, then surged by 545.56% to $2.3 million in 2025.
• Business Quant data shows CRMD's Operating Leases at $2.3 million in Q4 2025, $2.4 million in Q3 2025, and $258000.0 in Q2 2025.